UK markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
77.71+0.71 (+0.92%)
At close: 04:00PM EDT
77.90 +0.19 (+0.24%)
After hours: 07:57PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
14,707,000
14,240,000
12,682,000
11,888,000
9,913,000
Cost of revenue
4,514,000
4,345,000
3,956,000
3,711,000
3,510,000
Gross profit
10,193,000
9,895,000
8,726,000
8,177,000
6,403,000
Operating expenses
Research development
1,443,000
1,414,000
1,323,000
1,204,000
1,143,000
Selling general and administrative
5,339,000
5,190,000
4,520,000
4,359,000
3,787,000
Total operating expenses
7,666,000
7,478,000
6,693,000
6,353,000
5,719,000
Operating income or loss
2,527,000
2,417,000
2,033,000
1,824,000
684,000
Interest expense
269,000
265,000
470,000
341,000
361,000
Total other income/expenses net
-131,000
-188,000
-434,000
-412,000
-405,000
Income before tax
2,149,000
1,985,000
1,141,000
1,076,000
-79,000
Income tax expense
377,000
393,000
443,000
36,000
2,000
Income from continuing operations
1,771,000
1,592,000
698,000
1,041,000
-82,000
Net income
1,771,000
1,593,000
698,000
1,041,000
-82,000
Net income available to common shareholders
1,765,000
1,570,000
642,000
985,000
-115,000
Basic EPS
0.83
1.08
0.45
0.69
-0.08
Diluted EPS
0.82
1.07
0.45
0.69
-0.08
Basic average shares
1,444,825
1,453,000
1,430,500
1,422,300
1,416,700
Diluted average shares
1,455,000
1,463,500
1,439,700
1,433,800
1,416,700